S., & Shim, I
Dosing errors, contamination risk, storage problems, sterility issues, and inaccurate labeling can all create serious health concerns
What are some in-office procedures that these patients should consider
The goal is to improve how the body functions, reduce long-term health risks, and help patients feel better with a plan that fits their needs
GLP-1 receptor agonists such as semaglutide have demonstrated robust efficacy in obesity research, while dual GLP-1/GIP agonists like tirzepatide have pushed those results further
Unlike current blockbuster medications such as Ozempic, Wegovy, Mounjaro and Zepbound, retatrutide targets three hormone receptors -- GIP, GLP-1 and glucagon -- earning it the nickname of a "triple agonist" drug